Vertex Pharmaceuticals Incorporated (LON:0QZU)
469.42
+5.50 (1.19%)
At close: Jul 16, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 87.83 billion as of July 18, 2025. Its market cap has decreased by -8.73% in one year.
Market Cap
87.83B
Enterprise Value
80.60B
Revenue
8.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
469.42
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 87.83B, an increase of 171,395.10%. That is a compound annual growth rate of 24.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 159.91B |
GSK plc | 57.12B |
Haleon | 32.24B |
Smith & Nephew | 9.80B |
ConvaTec Group | 4.94B |
Hikma Pharmaceuticals | 4.40B |
HUTCHMED (China) | 2.16B |
Genus | 1.59B |